---
title: Levofloxacin + Metronidazole
description: >-
  Levofloxacin + Metronidazole is a fixed-dose combination antibiotic prescribed
  for treating various bacterial infections, particularly those involving both
  aerobic and anaerobic bacteria. It's commonly used for intra-abdominal
  infections, pelvic inflammatory disease, and certain types of skin and...
is_banned: false
lastModified: '2025-09-22T17:22:09.475Z'
faqs:
  - q: |-
      What is the recommended dosage for Levofloxacin + Metronidazole?**

      **A:** Refer to detailed dosage guidelines provided earlier.
    a: 'A:** Refer to detailed dosage guidelines provided earlier.'
  - q: |-
      What are the most common side effects?**

      **A:** Nausea, diarrhea, abdominal pain, and headache are common.
    a: 'A:** Nausea, diarrhea, abdominal pain, and headache are common.'
  - q: >-
      What are the serious side effects to watch out for?**


      **A:** Tendon rupture, peripheral neuropathy, seizures, and *C. difficile*
      infection are rare but serious side effects.
    a: >-
      A:** Tendon rupture, peripheral neuropathy, seizures, and *C. difficile*
      infection are rare but serious side effects.
  - q: >-
      Can this combination be used in pregnant or breastfeeding women?**


      **A:** No, it's contraindicated due to potential risks to the
      fetus/infant.
    a: 'A:** No, it''s contraindicated due to potential risks to the fetus/infant.'
  - q: >-
      Are there any specific drug interactions to be aware of?**


      **A:** Yes, interactions exist with antacids, cations (e.g., calcium,
      magnesium), warfarin, and alcohol.
    a: >-
      A:** Yes, interactions exist with antacids, cations (e.g., calcium,
      magnesium), warfarin, and alcohol.
  - q: |-
      How does renal impairment affect dosing?**

      **A:** Dose reduction is needed based on creatinine clearance levels.
    a: 'A:** Dose reduction is needed based on creatinine clearance levels.'
  - q: >-
      What monitoring is recommended during treatment?**


      **A:** Monitor renal and hepatic function, ECG for QT interval, signs of
      tendinitis, and neurological symptoms.
    a: >-
      A:** Monitor renal and hepatic function, ECG for QT interval, signs of
      tendinitis, and neurological symptoms.
  - q: >-
      Can this combination be used in children?**


      **A:** Use is generally avoided due to the risk of cartilage damage. If
      necessary, dose based on weight and condition.
    a: >-
      A:** Use is generally avoided due to the risk of cartilage damage. If
      necessary, dose based on weight and condition.
  - q: >-
      How long should the treatment typically last?**


      **A:** 7-14 days, depending on the infection type and severity.  Specific
      cases may require longer durations as determined by the physician.
    a: >-
      A:** 7-14 days, depending on the infection type and severity.  Specific
      cases may require longer durations as determined by the physician.
  - q: >-
      What types of infections is this combination commonly used for?**


      **A:** Intra-abdominal infections, pelvic inflammatory disease, and
      certain skin and soft tissue infections are common indications.
    a: >-
      A:** Intra-abdominal infections, pelvic inflammatory disease, and certain
      skin and soft tissue infections are common indications.
---
## **Usage**

Levofloxacin + Metronidazole is a fixed-dose combination antibiotic prescribed for treating various bacterial infections, particularly those involving both aerobic and anaerobic bacteria. It's commonly used for intra-abdominal infections, pelvic inflammatory disease, and certain types of skin and soft tissue infections.  It is also used to treat infections of the urinary tract, gynecological infections, and respiratory tract infections.

**Pharmacological Classification:** Antibiotic (fluoroquinolone and nitroimidazole combination).

**Mechanism of Action:**  Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication and repair. Metronidazole disrupts DNA synthesis and causes strand breakage in anaerobic bacteria and some protozoa.


## **Alternate Names**

No widely recognized alternate names exist for the combination itself, although individual components may have different names internationally.

**Brand Names:**  Several brand names exist depending on the region and manufacturer.


## **How It Works**

**Pharmacodynamics:**  Levofloxacin exerts bactericidal action against a broad spectrum of gram-positive and gram-negative bacteria. Metronidazole is effective against anaerobic bacteria and certain parasites.  The combination provides enhanced coverage against mixed infections.

**Pharmacokinetics:** Levofloxacin is well-absorbed orally and intravenously, achieving high tissue concentrations.  It's primarily excreted renally. Metronidazole is also well-absorbed with good tissue penetration. It is metabolized in the liver and excreted in urine. 

**Mode of Action:** Levofloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and repair. Metronidazole undergoes intracellular reductive activation, producing cytotoxic metabolites that damage bacterial DNA.

**Receptor Binding, Enzyme Inhibition, or Neurotransmitter Modulation:** Levofloxacin targets DNA gyrase and topoisomerase IV. Metronidazole interacts with DNA after reductive activation.


## **Dosage**


### **Standard Dosage**

#### **Adults:**  Levofloxacin 500-750 mg once daily + Metronidazole 500 mg every 8 hours or 1500 mg once daily, orally or intravenously, for 7-14 days depending on the infection. The duration may vary depending on the infection type and severity.


#### **Children:**  Use in children is generally avoided due to the risk of cartilage damage associated with fluoroquinolones. However, if deemed absolutely necessary by the physician, pediatric doses are calculated based on body weight and the specific infection being treated.

#### **Special Cases:**

- **Elderly Patients:** Dose adjustment may be needed based on renal function.
- **Patients with Renal Impairment:**  Dose reduction is necessary based on creatinine clearance.
- **Patients with Hepatic Dysfunction:**  Caution advised; dose reduction may be needed for severe liver disease.
- **Patients with Comorbid Conditions:** Dosage modifications may be needed in patients with diabetes, cardiovascular diseases, or other relevant conditions. 



### **Clinical Use Cases**

Specific dosing recommendations for clinical settings like intubation, surgical procedures, mechanical ventilation, ICU use, and emergency situations should be based on the individual patient's condition, infection severity, and local guidelines.  Consult infectious disease specialists for tailored recommendations.


### **Dosage Adjustments**

Dose adjustments based on renal/hepatic dysfunction, metabolic disorders, or genetic polymorphisms should be made carefully under the guidance of a physician or pharmacist.


## **Side Effects**


### **Common Side Effects:** Nausea, diarrhea, abdominal pain, headache, dizziness.

### **Rare but Serious Side Effects:** Tendinitis, tendon rupture, peripheral neuropathy, seizures, *Clostridioides difficile*-associated diarrhea, QT prolongation.

### **Long-Term Effects:** Peripheral neuropathy (rare), tendon damage.

### **Adverse Drug Reactions (ADR):** Anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis (rare).


## **Contraindications**

Hypersensitivity to levofloxacin, metronidazole, or other quinolones/nitroimidazoles.  Patients with epilepsy, history of tendon disorders, or myasthenia gravis.  Pregnancy and breastfeeding.


## **Drug Interactions**

Antacids, sucralfate, multivitamins (containing cations like calcium, magnesium, iron, zinc), theophylline, warfarin, NSAIDs, corticosteroids. Alcohol should be avoided due to a potential disulfiram-like reaction with metronidazole.


## **Pregnancy and Breastfeeding**

Contraindicated in pregnancy and breastfeeding due to potential risks to the fetus/infant.


## **Drug Profile Summary**

**Mechanism of Action:** Levofloxacin inhibits DNA gyrase and topoisomerase IV. Metronidazole damages DNA after reductive activation.

**Side Effects:** Nausea, diarrhea, headache, tendon rupture, peripheral neuropathy (rare).

**Contraindications:** Hypersensitivity, epilepsy, myasthenia gravis, pregnancy.

**Drug Interactions:** Antacids, cations, warfarin, alcohol.

**Pregnancy & Breastfeeding:** Contraindicated.

**Dosage:** Refer to detailed dosage guidelines above.

**Monitoring Parameters:**  Renal function, liver function,  ECG (for QT prolongation), signs of tendinitis, neurological status.



## **Popular Combinations**

While levofloxacin and metronidazole are commonly used together, they are not typically combined with other drugs.  For specific clinical scenarios, consult infectious disease specialists.



## **Precautions**

Assess renal and hepatic function before and during treatment. Monitor for signs of tendinitis, peripheral neuropathy, and *C. difficile* infection. Evaluate patients for history of epilepsy or myasthenia gravis.  Avoid alcohol during and shortly after therapy. Patients should avoid prolonged sun exposure and tanning beds.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Levofloxacin + Metronidazole?**

**A:** Refer to detailed dosage guidelines provided earlier.

### **Q2: What are the most common side effects?**

**A:** Nausea, diarrhea, abdominal pain, and headache are common.

### **Q3: What are the serious side effects to watch out for?**

**A:** Tendon rupture, peripheral neuropathy, seizures, and *C. difficile* infection are rare but serious side effects.

### **Q4:  Can this combination be used in pregnant or breastfeeding women?**

**A:** No, it's contraindicated due to potential risks to the fetus/infant.

### **Q5: Are there any specific drug interactions to be aware of?**

**A:** Yes, interactions exist with antacids, cations (e.g., calcium, magnesium), warfarin, and alcohol.

### **Q6:  How does renal impairment affect dosing?**

**A:** Dose reduction is needed based on creatinine clearance levels.

### **Q7: What monitoring is recommended during treatment?**

**A:** Monitor renal and hepatic function, ECG for QT interval, signs of tendinitis, and neurological symptoms.

### **Q8: Can this combination be used in children?**

**A:** Use is generally avoided due to the risk of cartilage damage. If necessary, dose based on weight and condition.

### **Q9: How long should the treatment typically last?**

**A:** 7-14 days, depending on the infection type and severity.  Specific cases may require longer durations as determined by the physician.

### **Q10: What types of infections is this combination commonly used for?**

**A:** Intra-abdominal infections, pelvic inflammatory disease, and certain skin and soft tissue infections are common indications.

